-+ 0.00%
-+ 0.00%
-+ 0.00%

CORBUS PHARMACEUTICALS PRESENTS PHASE 1B CANYON-1 CLINICAL TRIAL DATA FOR CRB-913 AT OBESITYWEEK® 2026

Reuters·11/16/2026 13:00:03

Please log in to view news